GLYFORMIN

This brand name is authorized in Cyprus, Malta, Nigeria, Singapore.

Active ingredients

The drug GLYFORMIN contains one active pharmaceutical ingredient (API):

1	Metformin UNII 9100L32L2N - METFORMIN
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GLYFORMIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BA02	Metformin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	MA084/00901
NG	Registered Drug Product Database	04-7968
Switch country to Nigeria in order to find specific presentations of GLYFORMIN
SG	Health Sciences Authority	06937P